Search results
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 20 hours agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative strategies ...
House Republicans’ Attempts to Attack Fauci Go Wildly Off Rails
The New Republic via Yahoo News· 3 days ago“No—I’m on the record, and I want to make sure that this is clear: that I developed a monoclonal ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...
Fauci Testimony Turns Chaotic: 'Most Insane Hearing I've Attended'
Rolling Stone· 3 days agoAnthony Fauci over his involvement in the response to the Covid-19 pandemic. Fauci was summoned...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 14 hours agoThe RSV market has altered substantially in recent years owing to the emergence of novel vaccines...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 3 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 6 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...
On a congressional COVID hearing, and weaponized uncertainty
Columbia Journalism Review· 19 hours agoAs the virus continued to spread, so did various versions of the theory. In February 2021, Facebook finally announced that it would remove any posts suggesting that the COVID
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoWhen Ezra Spier was diagnosed with long COVID in late 2022, his main symptom, postexertional malaise, caused fatigue so severe that it forced him to quit...
After key rare disease win, Annexon eyes $144 million raise - San Francisco Business Times
The Business Journals· 1 day agoAnnexon Inc. hopes to sell $125 million of stock following a late-stage clinical trial of a drug...